The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
Resonetics is moving deeper into the neuromodulation and structural heart markets with its latest deal. The Nashua, NH-based ...
Medical Device Network on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...
With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
Please provide your email address to receive an email when new articles are posted on . Artificial tears have long been the first option for patients with dry eye disease, but they only offer a ...
For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results